Cluster headache management with methylphenidate (Ritalin)

Headache

Volumn 38, Issue 9, 1998, Pages 710-712

  Mellick, Gary A ^a   Mellick, Larry B ^b  

^a American Pain Specialists Inc   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cluster headache; Methylphenidate; Ritalin; Sympathetic dysfunction

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLUSTER HEADACHE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FLUSHING; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PTOSIS; RHINORRHEA; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0031735743     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3809710.x     Document Type: Article

References (24)

1. D'Alessandro R, Gamberini G, Benassi G, Morganti G, Cortelli P, Lugaresi E. Cluster headache in the Republic of San Marino. Cephalalgia. 1986;6:159-162.
2. Fanciullacci M, Pietrini U, Gatto G, Boccuni M, Sicuteri F. Latent dysautonomic pupillary lateralization in cluster headache. A pupillometric study. Cephalalgia. 1982;2:135-144.
3. Salvesen R, Bogucki A, Wysocka-Bakowska MM, Antonaci F, Fredriksen TA, Sjaastad O. Cluster headache pathogenesis: a pupillometric study. Cephalalgia. 1987;7:273-284.
4. Havelius U, Milos P, Hindfelt B. Cephalic postganglionic sympathetic involvement in cluster headache-as evidenced by the pupillary responses to phenylephrine and tyramine. Eur J Neurol. 1997;4:352-359.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8 (suppl 7):1-96.
6. Ekbom K. Treatment of cluster headache in Europe. Headache Q. 1990;1:65-70.
7. Drummond PD. The site of sympathetic deficit in cluster headache. Headache. 1996;36:3-9.
8. Mellick G. An open clinical trial using methylphenidate (Ritalin®) in the management of pain of sympathetic origin. In: Abstracts of the 8th World Congress on Pain; 1996; Vancouver, British Columbia.
9. Mellick G. Methylphenidate (Ritalin®) management of complex regional pain syndrome type I (reflex sympathetic dystrophy) due to an electrical burn. Pain Digest. 1997;7:266-271.
10. Mellick G, Mellick L. Complex regional pain syndrome type I of the knee treated with methylphenidate (Ritalin®). Am J Pain Manage. 1998;8:78-82.
11. Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch Neurol. 1968;19:487-493.
12. Hannerz J, Hellstrom G, Klum T, Wahlgren NG. Cluster headache and "dynamite headache": blood flow velocities in the middle cerebral artery. Cephalalgia. 1990;10:31-38.
13. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. Cluster headache: transcranial Doppler ultrasound and rCBF studies. Cephalalgia. 1990; 10:87-94.
14. Ritalin® hydrochloride [package insert]. Summit, NJ: CIBA Pharmaceutical Company; 1992.
15. Johnstone M. The effects of methylphenidate on post-operative pain and vasoconstriction. Br J Anaesth. 1974;46:778-783.
16. Bruera E, Brenneis C, Paterson AH, MacDonald RN. Narcotics plus methylphenidate (Ritalin) for advanced cancer pain. Am J Nurs. 1988;88:1555-1556.
17. Bruera E, Brenneis C, Paterson AH, MacDonald RN. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1989;4:3-6.
18. Bruera E, Fainsinger R, MacEachern T, Hanson J. The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report. Pain. 1992;50:75-77.
19. Yee JD, Berde CB. Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. J Pain Symptom Manage. 1994;9:122-125.
20. Wilwerding MB, Loprinzi CL, Mailliard JA, et al. A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995;3:135-138.
21. Vigano A, Watanabe S, Bruera E. Methylphenidate for the management of somatization in terminal cancer patients. J Pain Symptom Manage. 1995;10:167-170.
22. Cantello R, Aguggia M, Gilli M, et al. Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiological implications. Arch Neurol. 1988;45:973-976.
23. Kuczenski R. Biochemical actions of amphetamine and other stimulants. In: Creese I, ed. Stimulants: Neurochemical, Behavioral and Clinical Perspectives. New York: Raven Press; 1983:31-61.
24. Geyer MA, Dawsey WJ, Mandell AJ. Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: a microspectrofluorimetric demonstration. Brain Res. 1975;85:135-139.